Bemis Stock To Go Ex-dividend Monday (BMS)

NEW YORK ( TheStreet) -- The ex-dividend date for Bemis (NYSE: BMS) is Monday, May 14, 2012. Owners of shares as of market close today will be eligible for a dividend of 25 cents per share. At a price of $31.58 as of 9:35 a.m. ET, the dividend yield is 3.1%.

The average volume for Bemis has been 724,700 shares per day over the past 30 days. Bemis has a market cap of $3.28 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 5.4% year to date as of the close of trading on Thursday.

Bemis Company, Inc. manufactures and sells flexible packaging products and pressure sensitive materials in North America, Latin America, Europe, and the Asia Pacific. The company operates in two segments, Flexible Packaging and Pressure Sensitive Materials. The company has a P/E ratio of 18.2, below the average consumer non-durables industry P/E ratio of 18.9 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Bemis as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Bemis Ratings Report.

See our dividend calendar or top-yielding stocks list.

null

More from Markets

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)